Optum guides members and providers through important upcoming formulary updates. See multiple tabs of linked spreadsheet for Select, Premium & UM Changes.
Firdapse® (amifampridine) – New orphan drug approval
November 28, 2018 - The FDA announced the approval of Catalyst Pharmaceutical’s Firdapse (amifampridine), for the treatment of Lambert-Eaton myasthenic syndrome (LEMS) in adults.
